ArisGlobal Releases New Version of Its Unified Electronic Data Capture System
agCapture 3.2 Delivers on the Promise of Real Unification of Data Management Processes
ArisGlobal, a leading provider of solutions to the life sciences industry, has announced the immediate availability of agCapture™ 3.2, the newest release of ArisGlobal’s innovative EDC (Electronic Data Capture) system, fully unified with ePRO (electronic Patient Reported Outcome) RTSM (Randomization and Trial Supply Management), IWRS (Interactive Web Response System) and medical coding, and seamlessly integrated with CTMS (Clinical Trial Management System). agCapture is offered either as an on-premise or cloud solution.
“Trial sponsors are constantly searching for ways to reduce study costs and improve efficiencies while adhering to compliance requirements,” stated Simon Sparkes, executive vice president, ArisGlobal. “agCapture is simply a stand-out EDC system that is not only unified with our advanced ePro, RTSM and IWRS solutions, but is now fully integrated with CTMS using CDISC ODM (Clinical Data Interchange Standards Consortium Operational Data Model) standards as the basis of the integration. There is quite simply no other clinical drug development platform to match the ArisGlobal eClinical solution suite.”
agCapture 3.2 delivers many key features and enhancements that ensure a successful clinical study:
- Greater flexibility and adaptability: While agCapture can support paper studies, study teams can now also easily create hybrid studies that combine both manual double data entry (DDE) and EDC. Sites can be specified as an EDC site or a traditional paper as required.
- Staging areas: Streamlines the study design process by supporting different design phases, making it easier to validate changes and manage the change control process even after a study is live.
- Advanced study builder: Users can easily create studies using standard CRF templates, optimizing the study setup time, design and validation process. This provides real benefits such as reducing study build time, standardizing the study design, achieving full data consolidation instantly and eliminating training.
- EDC to CTMS integration: Relevant status data is automatically transmitted from a company’s EDC system to their CTMS, triggering key activities such as investigator payments and monitoring visits. The transfer of data such as trial, visit, subject and CRF statuses, along with subject-specific identifiers is exchanged between the two modules using the CDISC- ODM standards.
- SAML-enabled solution: agCapture is also now a SAML-enabled (Security Assertion Markup Language) solution that supports single- sign-on, providing simplified access to data across multiple applications.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
